To evaluate if individuals with Dravet syndrome harbour a higher burden of additional rare variants compared to the control cohorts, we performed gene-based and gene-set collapsing analyses for rare variants across 190 epilepsy-related genes, excluding SCN1A. The gene discussed is SCN1A; the disease is encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.